CSL Limited

ASX:CSL.AX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

💉 Vaccines

Location

Australia

Market Cap

USD 82.33 B

Share Price

USD 170.04

Avg Daily Volume

766,787

Change (1 day)

-1.82%

Change (1 year)

-15.56%

Change (YTD)

-2.44%

CSL Limited Shareholders' Equity for the year ending June 30, 2024: USD 17.33 B

CSL Limited Shareholders' Equity is USD 17.33 B for the year ending June 30, 2024, a -26.90% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

CSL Limited Shareholders' Equity for the year ending June 30, 2023 was USD 23.72 B, a 11.87% change year over year.
CSL Limited Shareholders' Equity for the year ending June 30, 2022 was USD 21.20 B, a 152.92% change year over year.
CSL Limited Shareholders' Equity for the year ending June 30, 2021 was USD 8.38 B, a 27.59% change year over year.
CSL Limited Shareholders' Equity for the year ending June 30, 2020 was USD 6.57 B, a 25.58% change year over year.